Research Article

Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma

Figure 4

Specific cytotoxicity exhibited by EGFR-specific CAR-NK-92 cells against EGFR+ target cells. The cytotoxic activity of CAR-NK-92 and Ctrl-NK-92 cells against EGFRāˆ’ or EGFR+ cancer cells was determined using a 4ā€‰h lactate dehydrogenase (LDH) release assay in a dose-dependent manner. ; ; . ns: not significant.